AR036182A1 - Conjugados de biomoleculas y 1,4,7,10-tetraazaciclododecanos, un procedimiento para su preparacion, su uso para la preparacion de medios de diagnostico por resonancia magnetica nuclear o radiodiagnostico o para la radioterapia, los agentes farmaceuticos que los contienen, y los conjuntos o kits para - Google Patents
Conjugados de biomoleculas y 1,4,7,10-tetraazaciclododecanos, un procedimiento para su preparacion, su uso para la preparacion de medios de diagnostico por resonancia magnetica nuclear o radiodiagnostico o para la radioterapia, los agentes farmaceuticos que los contienen, y los conjuntos o kits paraInfo
- Publication number
- AR036182A1 AR036182A1 ARP020102718A ARP020102718A AR036182A1 AR 036182 A1 AR036182 A1 AR 036182A1 AR P020102718 A ARP020102718 A AR P020102718A AR P020102718 A ARP020102718 A AR P020102718A AR 036182 A1 AR036182 A1 AR 036182A1
- Authority
- AR
- Argentina
- Prior art keywords
- conjugates
- preparation
- hydrogen atom
- atoms
- chain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
- A61K49/143—Peptides, e.g. proteins the protein being an albumin, e.g. HSA, BSA, ovalbumin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Conjugados de biomoléculas y 1,4,7,10-tetraazaciclododecanos, de fórmula (1), donde Z representa un átomo de hidrógeno o al menos dos Z representan un equivalente de un ión metálico; B representa un átomo de hidrógeno o un radical alquilo C1-4; R representa un átomo de hidrógeno o un radical alquilo C1-10 lineal , o arilo ramificado o cíclico, saturado o insaturado, que está sustituido opcionalmente por un grupo carboxilo, -SO3H ó -PO3H2, y donde la cadena de alquilo del radical alquilo C1-10 contiene opcionalmente un grupo arilo y/o 1-2 átomos de oxígeno, con la condición de que los radicales B y R no representen al mismo tiempo átomos de oxígeno; A representa una cadena de hidrocarburos C1-30 lineal o ramificada, saturada o insaturada, que contiene opcionalmente 1-5 átomos de oxígeno, 1-5 átomos de nitrógeno y/o 1-5 radicales -NR', donde R' está definido como R, pero que puede seleccionarse de modo independiente, que está opcionalmente sustituido con 1-3 grupos carboxilo, 1-3 -SO3H, 1-3 -PO3H2 y/o 1-3 átomos de halógeno, donde están presentes opcionalmente 1-3 átomos de carbono como grupos carbonilo, donde la cadena o una parte de la cadena puede estar dispuesta en forma de anillo, y que está conformada de modo tal que X' está enlazado al menos a través de 3 átomos con el átomo de nitrógeno al que está unido A; X' representa el radical de un grupo X que reaccionó con una biomolécula, y Bio representa el radical de una biomolécula, sus sales, con la condición de que, cuando B es un átomo de hidrógeno y R es un radical alquilo C1-4, A no es el radical -CHR3-C(O)-NH-(CH2)1-6-NH-D- donde R3 es un átomo de hidrógeno o un radical alquilo C1-4; D es un grupo alquileno C1-4, de cadena lineal o ramificada, saturado o insaturado, que opcionalmente puede estar interrumpido o sustituido por un grupo carbonilo y D está unido a X. Estos conjugados son aptos como medios de contraste en el diagnóstico por RMN y radiodiagnóstico y como sustancia radioterapéutica. Con los ligandos especiales de los macrociclos se logra una elevada relajación y se posibilita un ajuste fino de la relajación. Un procedimiento para la preparación de los conjugados de fórmula (1), uso de estos últimos para la preparación de medios de diagnóstico por resonancia magnética nuclear o radiodiagnóstico o para la radioterapia, los agentes farmacéuticos que los contienen, y los conjuntos o kits para preparar radiofármacos que comprenden dichos conjugados.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10135355A DE10135355C1 (de) | 2001-07-20 | 2001-07-20 | Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie |
Publications (1)
Publication Number | Publication Date |
---|---|
AR036182A1 true AR036182A1 (es) | 2004-08-18 |
Family
ID=7692470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020102718A AR036182A1 (es) | 2001-07-20 | 2002-07-19 | Conjugados de biomoleculas y 1,4,7,10-tetraazaciclododecanos, un procedimiento para su preparacion, su uso para la preparacion de medios de diagnostico por resonancia magnetica nuclear o radiodiagnostico o para la radioterapia, los agentes farmaceuticos que los contienen, y los conjuntos o kits para |
Country Status (19)
Country | Link |
---|---|
US (2) | US20030206865A1 (es) |
EP (1) | EP1450864A2 (es) |
JP (1) | JP2004536889A (es) |
KR (1) | KR20040030825A (es) |
CN (1) | CN1301750C (es) |
AR (1) | AR036182A1 (es) |
AU (1) | AU2002355333B2 (es) |
BR (1) | BR0211150A (es) |
CA (1) | CA2453214A1 (es) |
DE (1) | DE10135355C1 (es) |
IL (1) | IL159291A0 (es) |
MX (1) | MXPA04000400A (es) |
NO (1) | NO20040239L (es) |
PE (1) | PE20030190A1 (es) |
PL (1) | PL366421A1 (es) |
RU (1) | RU2004105262A (es) |
TW (1) | TWI238722B (es) |
UY (1) | UY27389A1 (es) |
WO (1) | WO2003013617A2 (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7067111B1 (en) | 1999-10-25 | 2006-06-27 | Board Of Regents, University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
DK1286704T3 (da) * | 2000-06-02 | 2014-09-22 | Univ Texas | Ethylendicystein (EC)-glucose analoge konjugater |
DE10135356C1 (de) * | 2001-07-20 | 2003-04-17 | Schering Ag | Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen |
EP1466629A1 (en) | 2003-04-11 | 2004-10-13 | BRACCO IMAGING S.p.A. | Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for "CEST" applications |
DE10325752A1 (de) * | 2003-06-06 | 2004-12-30 | Faustus Forschungs Cie. Translational Cancer Research Gmbh | Lektin-Konjugate |
FR2856689A1 (fr) * | 2003-06-25 | 2004-12-31 | Guerbet Sa | Composes specifiques a forte relaxivite |
WO2004112840A2 (en) * | 2003-06-25 | 2004-12-29 | Guerbet | Peptide conjugate for magnetic resonance imaging |
US20070258888A1 (en) * | 2003-11-17 | 2007-11-08 | Claus Feldmann | Contrast Agent for Medical Imaging Techniques and Usage Thereof |
US9050378B2 (en) * | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
FR2868320B1 (fr) * | 2004-03-31 | 2007-11-02 | Centre Nat Rech Scient Cnrse | Agent de contraste pour l'imagerie par resonance magnetique |
CA2581639C (en) | 2004-09-30 | 2016-07-26 | Molecular Devices Corporation | Luminescent lanthanide complexes |
WO2006114738A2 (en) * | 2005-04-26 | 2006-11-02 | Koninklijke Philips Electronics N.V. | Mri contrast agents comprising cest active paramagnetic complex |
FI20055712A0 (fi) * | 2005-12-29 | 2005-12-29 | Wallac Oy | Makrosykliset oligonukleotiidien leimausreagenssit ja niistä johdetut konjugaatit |
US8758723B2 (en) * | 2006-04-19 | 2014-06-24 | The Board Of Regents Of The University Of Texas System | Compositions and methods for cellular imaging and therapy |
US10925977B2 (en) * | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
BRPI0906797A2 (pt) | 2008-01-09 | 2015-07-14 | Molecular Insight Pharm Inc | Inibidores de anidrase carbônica ix |
WO2010065906A2 (en) | 2008-12-05 | 2010-06-10 | Molecular Insight Pharmaceuticals, Inc. | Ca-ix specific radiopharmaceuticals for the treatment and imaging of cancer |
RU2539565C2 (ru) | 2008-12-05 | 2015-01-20 | Моликьюлар Инсайт Фармасьютикалз, Инк. | Са-ix специфические радиофармпрепараты для лечения и визуалазиции злокачественных опухолей |
EP2706057B1 (en) | 2008-12-05 | 2016-04-20 | Molecular Insight Pharmaceuticals, Inc. | Bis(imidazolyl)compounds and radionuclide complexes |
BR112012000209B8 (pt) | 2009-06-15 | 2021-07-27 | Molecular Insight Pharm Inc | heterodímeros de ácido glutâmico e seus processos de preparação |
CN101912623B (zh) * | 2010-08-24 | 2012-06-06 | 上海师范大学 | 具有靶向功能铁-钆双模式磁共振造影剂的制备及应用 |
CN102136339B (zh) * | 2011-01-24 | 2012-05-23 | 南开大学 | 一种具有铁磁、铁电双功能的镝单分子磁体及其制备方法 |
EP2800471A4 (en) | 2012-01-06 | 2015-11-04 | Molecular Insight Pharm Inc | METAL COMPLEX OF POLY (CARBOXYL) AMINE CONTAINING LIGANDS HAVING AFFINITY FOR CARBON IX ANHYDRASE |
HUE035739T2 (en) | 2013-01-14 | 2018-05-28 | Molecular Insight Pharm Inc | Triazine-based radiopharmaceuticals and radiological imaging agents |
WO2015075699A1 (en) * | 2013-11-25 | 2015-05-28 | Sanofi | Dotam derivatives for therapeutic use |
EP3101012A1 (en) | 2015-06-04 | 2016-12-07 | Bayer Pharma Aktiengesellschaft | New gadolinium chelate compounds for use in magnetic resonance imaging |
RU2755181C2 (ru) | 2016-11-28 | 2021-09-14 | Байер Фарма Акциенгезельшафт | Новые хелатные соединения гадолиния с высокой релаксивностью для применения в магнитно-резонансной визуализации |
RU2019139432A (ru) | 2017-05-05 | 2021-06-07 | Сентр фор Проуб Девелопмент энд Коммерсиализэйшн | Фармакокинетическая оптимизация бифункциональных хелатов и их применение |
WO2018204872A2 (en) | 2017-05-05 | 2018-11-08 | Fusion Pharmaceuticals Inc. | Igf-1r monoclonal antibodies and uses thereof |
US10093741B1 (en) | 2017-05-05 | 2018-10-09 | Fusion Pharmaceuticals Inc. | IGF-1R monoclonal antibodies and uses thereof |
MX2021006024A (es) | 2018-11-23 | 2021-07-06 | Bayer Ag | Formulacion de medios de contraste y proceso para prepararlos. |
FR3092580B1 (fr) * | 2019-02-08 | 2021-03-19 | Centre Nat Rech Scient | Nouveaux dérivés azobenzènes, leur procédé de préparation et leur utilisation pour le traitement thérapeutique associé à des radiations ionisantes |
EP3757098A1 (en) * | 2019-06-25 | 2020-12-30 | Ustav Organicke Chemie a Biochemie AV CR, v.v.i. | Cyclen based compounds, coordination compounds, peptides, pharmaceutical preparation, and use thereof |
KR102203368B1 (ko) * | 2020-10-30 | 2021-01-14 | 경북대학교 산학협력단 | 신규한 화합물 및 이를 함유하는 mri 조영제 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5049667A (en) * | 1987-04-14 | 1991-09-17 | Guerbet S.A. | Nitrogen-containing cyclic ligands |
JPH04154729A (ja) * | 1990-10-16 | 1992-05-27 | Nippon Mejifuijitsukusu Kk | 磁気共鳴造影剤 |
DE4115789A1 (de) * | 1991-05-10 | 1992-11-12 | Schering Ag | Makrocyclische polymer-komplexbildner, deren komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
KR930019648A (ko) * | 1992-03-27 | 1993-10-18 | 도키 가츠유키 | 테트라아자시클로도덴칸 유도체 및 그의 용도 |
KR100312357B1 (ko) * | 1992-12-09 | 2002-04-24 | 데이비드 이. 프랭크하우저 | 안정화된약제의에어로졸용액제제 |
US6693190B1 (en) * | 1994-05-11 | 2004-02-17 | Bracco International B.V. | Enhanced relaxivity monomeric and multimeric compounds |
US6045776A (en) * | 1996-12-04 | 2000-04-04 | Schering Aktiengesellschaft | Process for the production of metal-complex carboxylic acid amides |
US6113880A (en) * | 1997-12-17 | 2000-09-05 | Schering Aktiengesellschaft | Polyrotaxane derivatives for x-ray and nuclear magnetic resonance imaging |
DE19905094C1 (de) * | 1999-02-01 | 2000-10-12 | Schering Ag | Gadolinium (III)-Komplexe sowie ihre Verwendung für Zweischritt Strahlentherapieformen und diese enthaltende pharmazeutische Mittel |
-
2001
- 2001-07-20 DE DE10135355A patent/DE10135355C1/de not_active Expired - Fee Related
-
2002
- 2002-07-17 UY UY27389A patent/UY27389A1/es not_active Application Discontinuation
- 2002-07-18 KR KR10-2004-7000905A patent/KR20040030825A/ko not_active Application Discontinuation
- 2002-07-18 AU AU2002355333A patent/AU2002355333B2/en not_active Ceased
- 2002-07-18 BR BR0211150-0A patent/BR0211150A/pt not_active IP Right Cessation
- 2002-07-18 PL PL02366421A patent/PL366421A1/xx not_active Application Discontinuation
- 2002-07-18 JP JP2003518619A patent/JP2004536889A/ja active Pending
- 2002-07-18 CN CNB028145690A patent/CN1301750C/zh not_active Expired - Fee Related
- 2002-07-18 CA CA002453214A patent/CA2453214A1/en not_active Abandoned
- 2002-07-18 IL IL15929102A patent/IL159291A0/xx unknown
- 2002-07-18 EP EP02794507A patent/EP1450864A2/de not_active Withdrawn
- 2002-07-18 WO PCT/EP2002/008000 patent/WO2003013617A2/de active Application Filing
- 2002-07-18 MX MXPA04000400A patent/MXPA04000400A/es not_active Application Discontinuation
- 2002-07-18 RU RU2004105262/04A patent/RU2004105262A/ru not_active Application Discontinuation
- 2002-07-19 US US10/198,048 patent/US20030206865A1/en not_active Abandoned
- 2002-07-19 TW TW091116146A patent/TWI238722B/zh not_active IP Right Cessation
- 2002-07-19 PE PE2002000641A patent/PE20030190A1/es not_active Application Discontinuation
- 2002-07-19 AR ARP020102718A patent/AR036182A1/es unknown
-
2004
- 2004-01-19 NO NO20040239A patent/NO20040239L/no not_active Application Discontinuation
-
2006
- 2006-03-28 US US11/390,414 patent/US20070014725A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
UY27389A1 (es) | 2003-02-28 |
PE20030190A1 (es) | 2003-03-22 |
EP1450864A2 (de) | 2004-09-01 |
DE10135355C1 (de) | 2003-04-17 |
MXPA04000400A (es) | 2004-03-18 |
KR20040030825A (ko) | 2004-04-09 |
WO2003013617A2 (de) | 2003-02-20 |
BR0211150A (pt) | 2004-06-29 |
US20070014725A1 (en) | 2007-01-18 |
RU2004105262A (ru) | 2005-07-10 |
TWI238722B (en) | 2005-09-01 |
WO2003013617A3 (de) | 2004-06-10 |
JP2004536889A (ja) | 2004-12-09 |
NO20040239L (no) | 2004-01-19 |
US20030206865A1 (en) | 2003-11-06 |
CN1541114A (zh) | 2004-10-27 |
IL159291A0 (en) | 2004-06-01 |
CA2453214A1 (en) | 2003-02-20 |
AU2002355333B2 (en) | 2007-01-04 |
PL366421A1 (en) | 2005-01-24 |
CN1301750C (zh) | 2007-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR036182A1 (es) | Conjugados de biomoleculas y 1,4,7,10-tetraazaciclododecanos, un procedimiento para su preparacion, su uso para la preparacion de medios de diagnostico por resonancia magnetica nuclear o radiodiagnostico o para la radioterapia, los agentes farmaceuticos que los contienen, y los conjuntos o kits para | |
AR036183A1 (es) | 1,4,7,10-tetraazaciclododecanos, un procedimiento para su preparacion y su uso para la preparacion de un conjugado con una biomolecula | |
Caneschi et al. | Preparation, crystal structure, and magnetic properties of an oligonuclear complex with 12 coupled spins and an S= 12 ground state | |
AR034137A1 (es) | Un compuesto de biciclo-pirazol, su uso, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, y una biblioteca quimica combinatoria | |
ATE121082T1 (de) | Tri-azamakrozyklen und deren metall komplexe. | |
Simonneaux et al. | Structural, Magnetic, and Dynamic Characterization of the (d xz, dyz) 4 (dxy) 1 Ground-State Low-Spin Iron (III) Tetraphenylporphyrinate Complex [(p-TTP) Fe (2, 6-XylylNC) 2] CF3SO3 | |
DE602004002087D1 (de) | Bis(thio-hydrazid amid) verbindungen zur behandlung von mehrfach resistenten krebs | |
HUP0100568A2 (hu) | 11béta-Halogén-7alfa-helyettesített-ösztratriének, alkalmazásuk gyógyászati készítmények előállítására, valamint ilyen vegyületeket tartalmazó gyógyászati készítmények | |
ES2053779T3 (es) | Nuevos ligandos ciclicos nitrosos, los complejos metalicos formados por estos ligandos, composiciones de diagnostico que contienen estos complejos y procedimiento de preparacion de los ligandos. | |
Laugier et al. | Unusual magnetic properties of the adduct of copper chloride with 2-phenyl-4, 4, 5, 5-tetramethylimidazoline-1-oxyl 3-oxide | |
ES2007314A4 (es) | Compuestos de organopolisiloxano y amonio que contienen rodio, procedimiento para su preparacion y uso. | |
DE69029103D1 (de) | Tri-aza-Makrocyclen und Verfahren zu ihrer Herstellung | |
DE69223504T2 (de) | Bicycloazamakrocyclophosphon-Säure, Komplexe, Konjugate, Kontrastmittel und Herstellung | |
AT354621B (de) | Geraet zur erzeugung pulsierender magnet- felder fuer therapiezwecke | |
Keller et al. | 1H-NMR studies of the coordination geometry at the heme iron and the electronic structure of the heme group in cytochrome c-552 from Euglena gracilis | |
Böhme et al. | ENDOR studies of X-irradiated naphthalene single crystals | |
Chang | Conformational changes in ribosomal subunits following dissociation of the Escherichia coli 70 S ribosome | |
Holm et al. | Proton Contact Shifts in Dynamical Nickel (II) Complexes and the Detection of Diastereoisomers by Nuclear Resonance | |
Agrawal et al. | Radiosensitization of hypoxic mammalian cells by dinitroimidazoles | |
Wainwright et al. | Uptake and cell-killing activities of a series of Victoria blue derivatives in a mouse mammary tumour cell line | |
Mertes et al. | Structure of an iron (II) complex with a novel sexadentate ligand derived from a tetraaza macrocycle | |
DE68922686T2 (de) | Zyklische, Stickstoff enthaltende Liganden, ihre Metallkomplexe, diese enthaltende Diagnostik-Mittel und Verfahren zur Herstellung der Liganden. | |
AR035478A1 (es) | Acido amida-hidroxamico, acido acetilenico, beta-sulfonamido y fosfinico como inhibidores de la tace, uso de los mismos para la manufactura de un medicamento y composicion farmaceutica que los contiene | |
Gerosa et al. | In vitro analysis of BCNU‐sensitivity in human malignant gliomas: II. Cross‐resistance studies with cisplatinum and nitrosoureas | |
ES2040744T3 (es) | Un procedimiento para preparar derivados de 1,2,4-triazinona. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |